Orthofix Medical Inc. (OFIX)

Name: Orthofix Medical Inc. (OFIX) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0000884624 · Nasdaq · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Fiscal year ends Dec 23

For the year ended 2025-12-31, Orthofix Medical Inc. reported revenue of $822.31M. Revenue grew 2.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $833.19M.

Key ratios (year ended 2025-12-31)

68.8%

Gross margin

-9.9%

Operating margin

-11.2%

Net margin

-20.5%

Return on year-end equity

2.9%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$833.19M	$822.31M	$799.49M	$746.64M	$460.71M	$464.48M	$406.56M	$459.95M	$453.04M	$433.82M	$409.79M
Cost of Revenue	$239.07M	$256.30M	$253.61M	$260.37M	$123.54M	$114.91M	$101.89M	$100.61M	$96.63M	$93.04M	$87.85M
Gross Profit	$594.12M	$566.02M	$545.88M	$486.27M	$337.17M	$349.56M	$304.67M	$359.35M	$356.41M	$340.79M	$321.94M
R&D Expense	$61.41M	$65.85M	$73.64M	$80.23M	$49.06M	$49.62M	$39.06M	$34.64M	$33.22M	$29.70M	$28.80M
Operating Income	-$39.12M	-$81.43M	-$84.62M	-$139.11M	-$13.27M	-$8.31M	-$6.27M	-$18.78M	$30.09M	$40.81M	$21.07M
Depreciation & Amortization	$52.78M	$77.32M	$60.06M	$53.06M	$29.02M	$29.60M	$30.55M	$24.70M	$18.66M	$20.12M	$20.84M
EBITDA	$13.66M	-$4.11M	-$24.56M	-$86.05M	$15.75M	$21.28M	$24.28M	$5.92M	$48.75M	$60.94M	$41.91M
Net Income	-$61.72M	-$92.19M	-$126.00M	-$151.40M	-$19.75M	-$38.38M	$2.52M	-$28.46M	$13.81M	$6.22M	$3.06M
EPS (Diluted)	n/a	-$2.33	-$3.30	-$4.12	-$0.98	-$1.95	$0.13	-$1.51	$0.72	$0.34	$0.17
Total Assets	$873.02M	$850.65M	$893.29M	$925.32M	$458.63M	$476.62M	$525.86M	$495.62M	$466.64M	$405.35M	$372.10M
Total Liabilities	$443.84M	$400.61M	$390.17M	$326.58M	$121.77M	$139.69M	$169.00M	$167.99M	$131.24M	$108.75M	$108.63M
Long-Term Debt	n/a	n/a	$157.01M	$94.36M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders' Equity	$429.18M	$450.04M	$503.12M	$598.73M	$336.86M	$336.93M	$356.86M	$327.63M	$335.40M	$296.61M	$263.48M
Cash & Equivalents	$103.81M	$82.03M	$83.24M	$33.11M	$50.70M	$87.85M	$96.29M	$69.72M	$69.62M	$81.16M	$39.57M
Operating Cash Flow	$16.27M	$33.35M	$25.79M	-$45.75M	-$11.54M	$18.48M	$74.27M	$32.03M	$49.92M	$38.97M	$59.08M
Capital Expenditures	$44.09M	$34.63M	$34.88M	$62.05M	$23.16M	n/a	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	-$27.82M	-$1.28M	-$9.09M	-$107.80M	-$34.70M	n/a	n/a	n/a	n/a	n/a	n/a
Share Repurchases	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$63.42M
Shares Outstanding	40.73M	39.83M	38.49M	37.16M	20.16M	19.84M	19.42M	19.02M	18.58M	18.28M	17.83M
Weighted Average Diluted Shares	n/a	39.60M	38.13M	36.73M	20.05M	19.69M	19.39M	18.90M	18.91M	18.50M	18.46M
EPS (Basic)	n/a	-$2.33	-$3.30	-$4.12	-$0.98	-$1.95	$0.13	-$1.51	$0.73	$0.34	$0.17

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView